Related Experiment Videos
[Liver transplant in children. I]
N Ansaldi-Balocco1, N Cimadamore, C Barbera
1Istituto di Discipline Pediatriche, Università degli Studi di Torino, Italia.
Summary
Pediatric liver transplantation offers improved survival for end-stage liver disease, driven by advancements in immunosuppression like cyclosporine and surgical techniques. Donor organ availability remains a key challenge for pediatric liver transplants.
Area of Science:
- Hepatology
- Pediatric Surgery
- Immunology
Context:
- Liver transplantation is the sole definitive treatment for end-stage pediatric liver diseases.
- Recent survival improvements are attributed to cyclosporine, advanced surgical methods, and novel immunosuppressants.
Purpose:
- To outline the current landscape of pediatric liver transplantation, including indications, contraindications, and limitations.
- To highlight the critical role of immunosuppression and surgical advancements in improving outcomes for children with liver failure.
Summary:
- Key indications include biliary atresia, paucity of intrahepatic bile ducts, metabolic disorders (e.g., alpha-1 antitrypsin deficiency, hereditary tyrosinemia), post-infectious cirrhosis, acute liver failure, and hepatic malignancies.
- Absolute contraindications involve severe systemic illness, cardiac/renal failure, vascular abnormalities, sepsis, and HIV infection. Relative contraindications include malnutrition and certain viral markers.
- Significant limitations include the scarcity of appropriately sized donor livers for pediatric recipients and challenges in post-transplant family care and adherence.
Impact:
- Enhanced understanding of eligibility criteria and challenges in pediatric liver transplantation.
- Provides a foundation for future research into optimizing donor organ utilization and managing contraindications.
- Informs clinical decision-making and resource allocation for pediatric liver failure management.